current
approv
vaccin
small
molecul
therapeut
avail
prophylaxi
treatment
middl
east
respiratori
syndrom
coronaviru
merscov
infect
merscov
proteas
essenti
viral
replic
consequ
attract
target
provid
potenti
effect
mean
develop
small
molecul
therapeut
combat
merscov
describ
herein
structureguid
design
evalu
novel
class
inhibitor
merscov
proteas
embodi
piperidin
moieti
design
element
wellsuit
exploit
favor
subsit
bind
interact
attain
optim
pharmacolog
activ
pk
properti
mechan
action
compound
structur
determin
associ
bind
illumin
use
xray
crystallographi
protein
spike
glycoprotein
e
envelop
protein
membran
glycoprotein
n
nucleocapsid
protein
play
critic
role
virioncel
receptor
bind
replic
virion
assembl
locat
end
genom
coronaviru
entri
initi
bind
spike
protein
cell
receptor
specif
dipeptidyl
peptidas
angiotensin
convert
enzym
merscov
sarscov
respect
entri
cell
requir
host
proteas
cleavag
two
site
protein
case
cov
translat
genom
mrna
yield
polyprotein
second
polyprotein
product
ribosom
frame
shift
join
togeth
encod
papainlik
cystein
proteas
plpro
cystein
proteas
polyprotein
process
cleavag
site
plpro
cleavag
site
result
sixteen
matur
nonstructur
protein
includ
rnadepend
rna
polymeras
rdrp
helicas
play
import
role
transcript
replic
coronavirus
fig
proteas
essenti
viral
replic
make
attract
target
drug
develop
merscov
chymotrypsinlik
cystein
proteas
catalyt
dyad
extend
bind
site
proteas
display
stringent
primari
substrat
specif
p
gln
residu
strong
prefer
p
leu
residu
p
residu
side
chain
orient
toward
solvent
subsit
shallow
prefer
small
hydrophob
p
residu
ala
function
structur
studi
delin
similar
coronavirus
exploit
design
broadspectrum
inhibitor
recent
report
first
demonstr
clinic
efficaci
coronaviru
proteas
inhibitor
dipeptidyl
aldehyd
bisulfit
adduct
inhibitor
design
specif
administr
cat
infect
fipv
coronaviru
fatal
cat
revers
progress
fatal
fip
result
clinic
remiss
major
anim
sinc
fip
diseas
progress
quit
rapid
pathogenesi
primarili
immunemedi
featur
share
merscov
hypothes
viral
proteas
inhibitor
could
revers
pathogenesi
merscov
affect
host
interrog
hypothesi
entail
first
step
design
new
versatil
class
peptidomimet
inhibitor
merscov
proteas
describ
herein
structureguid
design
inhibitor
merscov
embodi
piperidin
moieti
novel
design
element
well
pertin
structur
biochem
studi
inhibitor
also
examin
coronavirus
includ
sarscov
fipv
mhv
evalu
spectrum
activ
multipl
coronavirus
structureguid
design
inhibitor
encompass
follow
step
first
determin
high
resolut
xray
crystal
structur
merscov
complex
fig
examin
activ
site
complex
reveal
aldehyd
bisulfit
adduct
revert
precursor
peptidyl
aldehyd
subsequ
form
tetrahedr
hemithioacet
upon
reaction
activ
site
notabl
electron
densiti
stereocent
consist
format
r
enantiom
coval
bind
site
also
observ
structur
describ
follow
section
structur
reveal
network
backbon
hydrogen
bond
ensur
correct
posit
inhibitor
activ
site
well
two
critic
hydrogen
bond
p
gln
surrog
side
chain
inhibitor
p
leu
side
chain
ensconc
hydrophob
subsit
enzym
importantli
structur
show
hydrophobicdriven
interact
benzyl
group
inhibitor
glactam
ring
gln
surrog
side
chain
b
base
forgo
reason
extend
cap
would
allow
inhibitor
assum
extend
conform
orient
phenyl
ring
toward
hydrophob
pocket
enzym
valid
idea
obtain
synthes
extend
inhibitor
determin
high
resolut
xray
crystal
structur
merscov
complex
fig
b
mcl
phenethyl
side
chain
clearli
shown
occupi
hydrophob
subsit
addit
array
hbond
backbon
inhibitor
serv
correctli
posit
inhibitor
activ
site
inhibitor
interact
subsit
subsit
c
hypothes
attach
piperidin
ring
peptidyl
compon
would
yield
structur
novel
peptidomimet
capabl
orient
recognit
element
r
r
correct
vector
relationship
optim
interact
subsit
render
dipeptidyl
inhibitor
equival
tetrapeptidyl
inhibitor
potenti
diminish
pk
liabil
provid
flexibl
mean
structureguid
parallel
optim
admetpk
physicochem
properti
use
divers
site
r
r
inhibitor
fig
summari
piperidinebas
design
strategi
hitherto
unrecogn
effect
mean
render
dipeptidyl
inhibitor
equival
tetrapeptidyl
inhibitor
capabl
engag
optim
bind
interact
four
subsit
howev
anticip
display
diminish
pk
liabil
due
reduc
peptidyl
charact
furthermor
aforement
piperidinebas
design
strategi
wide
applic
extend
proteas
extend
bind
site
preliminari
evid
support
approach
provid
result
enzym
cellbas
screen
deriv
tabl
well
result
structur
studi
vide
infra
see
tabl
synthesi
final
compound
af
af
outlin
scheme
react
differ
grignard
reagent
yield
correspond
deriv
reflux
l
leucin
methyl
ester
hydrochlorid
trichloromethyl
chloroform
yield
isocyan
react
commerciallyavail
nsubstitut
form
correspond
carbam
adduct
hydrolyz
correspond
acid
lithium
hydroxid
aqueou
thf
subsequ
coupl
glutamin
surrog
methyl
ester
hydrochlorid
afford
desir
dipeptidyl
ester
either
treat
lithium
borohydrid
directli
first
treat
dri
hcl
dioxan
follow
reaction
alkyl
sulfonyl
chlorid
alkyl
chloroform
yield
ester
prior
reduct
lithium
borohydrid
yield
alcohol
af
dessmartin
oxid
follow
flash
chromatographi
yield
pure
aldehyd
af
enantiomer
puriti
aldehyd
consist
high
amount
epimer
aldehyd
rang
correspond
bisulfit
adduct
af
readili
obtain
white
solid
stir
aldehyd
sodium
bisulfit
ethyl
acet
water
mixtur
synthes
compound
list
tabl
inhibitori
activ
synthes
compound
merscov
sarscov
fipv
antivir
activ
two
repres
compound
compound
cellbas
system
includ
merscov
fipv
mhv
evalu
describ
experiment
section
ic
ec
cc
valu
list
tabl
averag
least
two
determin
evid
deriv
function
highli
potent
inhibitor
test
coronavirus
enzym
tabl
cell
base
assay
tabl
fig
importantli
repres
aldehyd
bisulfit
adduct
compound
display
potent
inhibit
toward
merscov
enzym
cellbas
system
low
cytotox
cc
mm
tabl
fig
exampl
compound
select
index
si
cc
ec
except
compound
aldehyd
aldehyd
bisulfit
adduct
found
compar
vitro
potenc
toward
merscov
furthermor
pharmacolog
activ
found
depend
natur
r
group
compound
less
activ
toward
merscov
compound
order
establish
mechan
action
well
obtain
structur
inform
use
guid
optim
pharmacolog
activ
high
resolut
xray
crystal
structur
sever
deriv
bound
merscov
determin
includ
cocryst
structur
merscov
inhibitor
complex
fig
format
tetrahedr
adduct
via
reaction
aldehyd
gener
aldehyd
bisulfit
adduct
crystal
condit
use
activ
site
cystein
clearli
evid
confirm
mechan
action
inspect
structur
reveal
presenc
promin
electron
densiti
consist
structur
inhibitor
howev
nbocpiperidinyl
moieti
disord
posit
orient
benzyl
group
suggest
piperidin
ring
like
project
toward
subsit
inhibitor
bound
activ
site
enzym
via
network
backbon
hbond
fig
addit
hbond
serv
stabil
hemithioacet
tetrahedr
adduct
also
clearli
evid
three
critic
hbond
involv
p
gln
surrog
ring
oxygen
nitrogen
hbond
interact
near
ident
inhibitor
fig
b
structur
complementar
inhibitor
also
evid
electrostat
surfac
represent
enzym
two
inhibitor
nestl
activ
site
fig
cocryst
structur
merscov
aldehyd
bisulfit
adduct
complex
also
show
crystal
condit
use
aldehyd
bisulfit
adduct
revert
precursor
aldehyd
subsequ
form
tetrahedr
adduct
activ
site
cystein
fig
piperidinyl
moieti
disord
consequ
precis
locat
could
discern
howev
inhibitor
engag
hbond
interact
inhibitor
fig
merscov
constitut
global
public
health
concern
current
licens
vaccin
antivir
drug
prevent
treatment
coronaviru
infect
disclos
herein
first
time
design
util
gener
class
piperidinebas
peptidomimet
inhibitor
coronaviru
proteas
attach
piperidin
moieti
dipeptidyl
compon
permit
result
hybrid
inhibitor
engag
favor
bind
interact
subsit
enzym
importantli
approach
disclos
herein
extend
proteas
medic
relev
final
disclos
compound
potent
inhibit
merscov
mechan
action
mode
bind
merscov
proteas
illumin
use
xray
crystallographi
reagent
dri
solvent
purchas
variou
chemic
supplier
aldrich
acro
organ
chemimpex
tci
america
bachem
use
obtain
silica
gel
mesh
use
flash
chromatographi
purchas
sorbent
technolog
atlanta
ga
thin
layer
chromatographi
perform
use
analtech
silica
gel
plate
visual
accomplish
dropwis
n
atmospher
solut
mmol
dri
thf
ml
ice
bath
kept
c
reaction
mixtur
stir
h
room
temperatur
n
atmospher
monitor
complet
reaction
tlc
reaction
mixtur
dilut
water
ml
solut
acidifi
use
hydrochlor
acid
solvent
remov
rotari
evapor
residu
extract
ethyl
acet
ml
layer
separ
organ
layer
wash
brine
ml
dri
anhydr
sodium
sulfat
filter
concentr
yield
colorless
oili
product
purifi
flash
chromatographi
yield
synthesi
l
leucin
methyl
ester
isocyan
l
leucin
methyl
ester
hydrochlorid
mmol
place
dri
rb
flask
dri
overnight
vacuum
pump
flask
flush
nitrogen
dri
dioxan
ml
ad
follow
trichloromethyl
chloroform
g
mmol
reaction
mixtur
reflux
h
solvent
remov
rotari
evapor
residu
vacuum
distil
yield
pure
isocyan
colorless
oil
tabl
crystallograph
data
merscov
complex
compound
merscov
merscov
compound
merscov
compound
hkl
c
r
factor
hkl
jjf
ob
hkl
j
jf
calc
hkl
hkl
jf
ob
hkl
j
rfree
calcul
ident
manner
use
randomli
select
reflect
includ
refin
r
mea
redundancyindepend
multiplicityweight
r
merg
r
pim
precisionind
multiplicityweight
r
merg
e
cc
correl
coeffici
mean
intens
two
random
halfset
data
synthesi
substitut
piperidinederiv
carbam
gener
procedur
solut
substitut
unsubstitut
mmol
dri
acetonitril
ml
treat
triethylamin
g
mmol
follow
amino
acid
methyl
ester
isocyan
mmol
result
solut
reflux
h
allow
cool
room
temperatur
solut
concentr
residu
taken
ethyl
acet
ml
organ
layer
wash
hcl
ml
brine
ml
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
leav
compound
colorless
oil
synthesi
acid
gener
procedur
solut
ester
mmol
tetrahydrofuran
ml
treat
lioh
ml
reaction
mixtur
stir
h
room
temperatur
disappear
ester
monitor
tlc
solvent
evapor
residu
dilut
water
ml
solut
acidifi
use
hydrochlorid
acid
ml
aqueou
layer
extract
ethyl
acet
ml
combin
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
yield
correspond
compound
colorless
oil
synthesi
compound
gener
procedur
edci
g
mmol
eq
hobt
g
mmol
eq
ad
solut
compound
mmol
dri
dmf
ml
mixtur
stir
min
room
temperatur
separ
flask
solut
deprotect
glutamin
surrog
g
mmol
dmf
ml
cool
c
treat
diisopropylethylamin
diea
g
mmol
eq
stir
min
ad
reaction
mixtur
contain
acid
reaction
mixtur
stir
h
monitor
reaction
tlc
solvent
remov
residu
partit
ethyl
acet
ml
citric
acid
ml
layer
separ
ethyl
acet
layer
wash
satur
aqueou
nahco
ml
follow
satur
nacl
ml
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
yield
yellowcolor
oili
product
purif
flash
chromatographi
yield
ester
white
solid
synthesi
compound
gener
procedur
hcl
dioxan
ml
ad
solut
compound
mmol
dri
dcm
ml
mixtur
stir
h
room
temperatur
solvent
remov
residu
dri
high
vacuum
h
product
dissolv
dri
thf
ml
appropri
alkyl
sulfonyl
chlorid
alkyl
chloroform
deriv
eq
ad
solut
stir
reaction
mixtur
stir
h
room
temperatur
residu
dissolv
ethyl
acet
ml
wash
hcl
ml
ethyl
acet
layer
wash
satur
nacl
ml
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
yield
crude
product
purif
flash
chromatographi
yield
correspond
ester
white
solid
lithium
borohydrid
thf
ml
mmol
ad
dropwis
solut
ester
mmol
anhydr
thf
ml
follow
absolut
ethyl
alcohol
ml
reaction
mixtur
stir
room
temperatur
overnight
reaction
mixtur
acidifi
ad
hcl
ph
adjust
remov
solvent
left
residu
taken
ethyl
acet
ml
organ
layer
wash
brine
ml
dri
anhydr
sodium
sulfat
filter
concentr
yield
compound
af
white
solid
compound
af
mmol
dissolv
anhydr
dichloromethan
ml
nitrogen
atmospher
cool
c
dessmartin
periodinan
reagent
g
mmol
eq
ad
reaction
mixtur
stir
ice
bath
remov
reaction
mixtur
stir
room
temperatur
h
monitor
tlc
indic
complet
disappear
start
materi
solut
aqueou
sodium
thiosulf
ml
ad
solut
stir
anoth
min
aqueou
layer
remov
organ
layer
wash
aqueou
sodium
thiosulf
ml
follow
satur
aqueou
sodium
bicarbon
ml
water
ml
brine
ml
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
yellow
residu
purifi
flash
chromatographi
silica
gelmethylen
chlorid
ethyl
acetatemethanol
yield
white
solid
af
absolut
ethanol
ml
ad
solut
aldehyd
af
mmol
dri
ethyl
acet
ml
stir
follow
solut
sodium
bisulfit
mg
mmol
water
ml
reaction
mixtur
stir
h
c
reaction
mixtur
allow
cool
room
temperatur
vacuum
filter
solid
thoroughli
wash
absolut
ethanol
filtrat
dri
anhydr
sodium
sulfat
filter
concentr
yield
yellowish
oil
oili
product
treat
ethyl
ether
ml
form
white
solid
white
solid
stir
ethyl
ether
ml
ethyl
acet
ml
min
care
remov
solvent
use
pipett
left
correspond
aldehyd
bisulfit
adduct
af
white
solid
fret
proteas
assay
perform
prepar
stock
solut
substrat
dabcylktsavlqsgfrkmeedan
deriv
cleavag
site
viral
polyprotein
sarscov
inhibitor
dmso
dilut
assay
buffer
compris
mm
hepe
buffer
ph
contain
nacl
mm
edta
mm
glycerol
mm
dithiothreitol
dtt
express
purif
merscov
sarscov
fipv
perform
standard
method
describ
previous
lab
proteas
merscov
sarscov
fipv
mix
serial
dilut
compound
dmso
ml
assay
buffer
incub
c
min
follow
addit
ml
assay
buffer
contain
substrat
fluoresc
read
obtain
use
excit
wavelength
nm
emiss
wavelength
nm
fluoresc
micropl
reader
biotec
winoosk
vt
h
follow
addit
substrat
rel
fluoresc
unit
rfu
determin
subtract
background
valu
substratecontain
well
without
proteas
raw
fluoresc
valu
describ
previous
dosedepend
fret
inhibit
curv
fit
variabl
slope
use
graphpad
prism
softwar
graphpad
la
jolla
ca
order
determin
ic
valu
inhibitor
effect
compound
replic
merscov
fipv
examin
crfk
cell
respect
briefli
confluent
semiconflu
cell
infect
moi
pfucel
follow
adsorpt
cell
incub
medium
contain
dmso
compound
mm
h
incub
viral
titer
determin
tcid
fipv
mhv
plaqu
assay
merscov
ec
valu
determin
use
graphpadpr
softwar
cytotox
dose
cell
death
cc
compound
determin
crfk
cell
confluent
cell
grown
plate
treat
variou
concentr
mm
compound
h
cell
cytotox
measur
cytotox
nonradioact
cytotox
assay
kit
promega
madison
wi
vitro
therapeut
index
calcul
divid
cc
ec
purifi
merscov
mm
nacl
mm
tri
ph
concentr
mgml
mm
stock
solut
mm
compound
compound
prepar
dmso
complex
mer
prepar
mix
concentr
protein
supplement
mm
compound
incub
overnight
c
crystal
experi
conduct
use
compact
rigaku
reagent
sit
drop
vapor
diffus
plate
c
use
equal
volum
protein
crystal
solut
equilibr
ml
latter
crystal
mer
complex
compound
compound
display
prismat
morpholog
obtain
index
ht
screen
hampton
research
condit
wv
peg
mm
bistri
ph
mm
mgcl
day
crystal
complex
obtain
index
ht
screen
hampton
research
condit
vv
peg
mme
mm
bistri
ph
mm
cacl
sampl
transfer
fresh
drop
contain
crystal
vv
peg
store
liquid
nitrogen
xray
diffract
data
collect
advanc
photon
sourc
beamlin
use
dectri
pilatu
pixel
array
detector
intens
integr
use
xd
use
autoproc
laue
class
analysi
data
scale
perform
aimless
suggest
highest
probabl
laue
class
space
group
structur
solut
conduct
molecular
replac
phaser
use
previous
determin
isomorph
structur
mer
pdb
search
model
structur
refin
manual
model
build
conduct
phenix
coot
respect
disord
side
chain
truncat
point
electron
densiti
could
observ
structur
valid
conduct
molprob
figur
prepar
use
packag
coordin
structur
factor
mer
inhibitor
complex
deposit
worldwid
protein
data
bank
wwpdb
access
code
inhibitor
inhibitor
